Compare SEER & SHIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SEER | SHIM |
|---|---|---|
| Founded | 2017 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.0M | 128.6M |
| IPO Year | 2020 | 2023 |
| Metric | SEER | SHIM |
|---|---|---|
| Price | $1.74 | $2.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $4.00 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 167.0K | 72.4K |
| Earning Date | 11-10-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 9.40 | ★ 81.95 |
| EPS | N/A | ★ N/A |
| Revenue | $16,578,000.00 | ★ $492,844,000.00 |
| Revenue This Year | N/A | $1.41 |
| Revenue Next Year | $20.50 | $20.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 16.99 | 2.63 |
| 52 Week Low | $1.55 | $1.95 |
| 52 Week High | $2.38 | $6.76 |
| Indicator | SEER | SHIM |
|---|---|---|
| Relative Strength Index (RSI) | 32.98 | 40.59 |
| Support Level | $1.70 | $2.45 |
| Resistance Level | $1.81 | $4.08 |
| Average True Range (ATR) | 0.10 | 0.16 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 25.00 | 59.65 |
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
Shimmick Corp is engaged in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resiliency, and sustainable transportation. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains critical infrastructure, including mass transit, bridges, and military infrastructure. The company has one operating and reportable segment: infrastructure solutions. All of its revenue is derived from the United States.